![SciELO - Brasil - Inclusion-body myositis: a difficult diagnosis? Inclusion-body myositis: a difficult diagnosis? SciELO - Brasil - Inclusion-body myositis: a difficult diagnosis? Inclusion-body myositis: a difficult diagnosis?](https://minio.scielo.br/documentstore/1678-4774/QLgbwjQRYgDv65WZrSkBF7z/bfe2a471b1dee2d2fb487961f8258d9e34380fc1.jpg)
SciELO - Brasil - Inclusion-body myositis: a difficult diagnosis? Inclusion-body myositis: a difficult diagnosis?
![Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken | Acta Neuropathologica Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken | Acta Neuropathologica](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00401-015-1384-5/MediaObjects/401_2015_1384_Fig1_HTML.jpg)
Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken | Acta Neuropathologica
![Phenotypical statin‐associated immune‐mediated necrotizing myositis with histological features of inclusion body myositis | Rheumatology & Autoimmunity Phenotypical statin‐associated immune‐mediated necrotizing myositis with histological features of inclusion body myositis | Rheumatology & Autoimmunity](https://mednexus.org/cms/asset/2e124bc9-189a-462e-9d1c-75b12ebc32a4/rai212059-gra-0001.png)
Phenotypical statin‐associated immune‐mediated necrotizing myositis with histological features of inclusion body myositis | Rheumatology & Autoimmunity
![Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial - The Lancet Rheumatology Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/dad580fb-1278-4fc7-ae5b-1f405d46bc90/gr1.gif)
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial - The Lancet Rheumatology
![Clinical features of patients with inclusion body myositis. (a) Atrophy... | Download Scientific Diagram Clinical features of patients with inclusion body myositis. (a) Atrophy... | Download Scientific Diagram](https://www.researchgate.net/publication/342770624/figure/fig1/AS:919303083786240@1596190343522/Clinical-features-of-patients-with-inclusion-body-myositis-a-Atrophy-of-finger.png)
Clinical features of patients with inclusion body myositis. (a) Atrophy... | Download Scientific Diagram
![Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches - The Lancet Neurology Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches - The Lancet Neurology](https://www.thelancet.com/cms/attachment/bd645874-312e-4be0-b348-c647904c99b2/gr1.jpg)